Atlas Trials

Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS

Clinical trial NCT03521596 · COMPLETED

Trial details

NCT number
NCT03521596
Sponsor
Fondazione Italiana Linfomi - ETS
Status
COMPLETED
Study type
OBSERVATIONAL
Waldenstrom Macroglobulinemia
Start date
2018-08-28
Primary completion
2020-10-06
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.